SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Labwire Inc.
LBWR 0.00010000.0%Oct 24 3:23 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: shortsinthesand who wrote (838)5/12/2008 7:30:02 PM
From: creede  Read Replies (1) of 1698
 
Shorts, what you have said might be significant, if it were not for the fact that Labwire has already submitted a 23 page Form 10 that supercedes what you are saying.

sec.gov

It passed without comment, remember?

Labwire Becomes an SEC Reporting Company
Wednesday May 7, 10:00 am ET

HOUSTON, TX--(MARKET WIRE)--May 7, 2008 -- Labwire, Inc. (Other OTC:LBWR.PK - News), a leading provider of employee screening solutions, canine security, and compliance surveillance services, is pleased to report that on April 14, 2008 Labwire (trading symbol: lbwr) became a reporting company with the U.S. Securities and Exchange Commission. As a result, the company will be filing with the SEC periodic reports containing up-to-date information about the company, and the company will be subject to additional requirements enhancing investor protection.
ADVERTISEMENT


The necessary steps are now being taken to have the company's common stock traded on the OTC-BB (Bulletin Board). Management is now interviewing market makers and upon completion of the selection process projects the move to OTC-BB trading in approximately six weeks.

During this time, management is transitioning into the status of a full-reporting public company. "We are working with our auditors to complete the 2007 annual audit as well as a review of our books and financial activity for 2008. We are getting everything prepared so that we can commence filing our periodic reports," stated Marlin Williford, Labwire CFO.

Dexter Morris, Labwire Chairman and CEO, offers the following business insight: "We are excited about being an SEC reporting company and the possibilities that it permits having our common stock traded on the OTC Bulletin Board. These have been two of our major objectives for some time and it is a management priority to bring this process to a successful conclusion as soon as possible. Business prospects continue to be bright and I look forward to sharing progress with our shareholders as our marketing efforts turn opportunities into new contracts and increased business with existing clients in the coming months. We are entering our busy cycle for business development and I am very excited about the opportunities we are seeing in the marketplace."

About Labwire:

Labwire Inc., Headquartered in Houston, TX, provides secure and compliant employee drug screening and background checking services to Fortune 500 corporations via the Labwire(TM) Platform. Labwire(TM) is a proprietary, web-based application that streamlines the complex regulatory and record management activities associated with employee screening, delivering accurate timely results while eliminating service calls and paper trails. This comprehensive solution to managing employee screening services is the most efficient and cost-effective platform in the industry.

GB-ND
creede
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext